Total Payments
$1,284
2024 Payments
$80.90
Companies
13
Transactions
23
Medicare Patients
1,547
Medicare Billing
$67,666
Payment Breakdown by Category
Food & Beverage$1,284 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,284 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $231.75 | 2 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $229.21 | 2 | $0 (2019) |
| Horizon Therapeutics plc | $228.84 | 2 | $0 (2023) |
| Glaukos Corporation | $205.49 | 3 | $0 (2023) |
| Heru, Inc. | $141.12 | 1 | $0 (2022) |
| PFIZER INC. | $71.69 | 4 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $39.10 | 2 | $0 (2023) |
| Alcon Vision LLC | $35.48 | 1 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.46 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.30 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.90 | 4 | PFIZER INC. ($23.22) |
| 2023 | $441.61 | 8 | Horizon Therapeutics plc ($228.84) |
| 2022 | $223.05 | 3 | Heru, Inc. ($141.12) |
| 2021 | $17.58 | 1 | Amgen Inc. ($17.58) |
| 2020 | $35.48 | 1 | Alcon Vision LLC ($35.48) |
| 2019 | $253.76 | 4 | Regeneron Healthcare Solutions, Inc. ($119.16) |
| 2018 | $119.45 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($119.45) |
| 2017 | $112.59 | 1 | Regeneron Healthcare Solutions, Inc. ($112.59) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: DIABETES | ||||||
| 06/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Gastroenterology | ||||||
| 05/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/20/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug), VYZULTA | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Ophthalmology | ||||||
| 10/11/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Gastroenterology | ||||||
| 09/05/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Ophthalmology | ||||||
| 08/21/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/27/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $103.86 | General |
| Category: TEPEZZA | ||||||
| 07/11/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/03/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $123.56 | General |
| 02/08/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: TEPEZZA | ||||||
| 10/20/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device), IACCESS | Food and Beverage | Cash or cash equivalent | $56.27 | General |
| Category: GLAUCOMA | ||||||
| 10/18/2022 | GLAUKOS CORPORATION | ISTENT (Device), ISTENT INJECT W | Food and Beverage | Cash or cash equivalent | $25.66 | General |
| Category: GLAUCOMA | ||||||
| 05/18/2022 | Heru, Inc. | Heru HMD (Device) | Food and Beverage | Cash or cash equivalent | $141.12 | General |
| Category: Ophthalmic | ||||||
| 07/14/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Neuroscience | ||||||
| 02/17/2020 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $35.48 | General |
| Category: Ophthalmology | ||||||
| 11/13/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $119.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/23/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $109.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/17/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Diabetes | ||||||
| 05/22/2019 | PFIZER INC. | EUCRISA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $119.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/12/2017 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $112.59 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 362 | 407 | $43,167 | $14,723 |
| 2022 | 8 | 316 | 330 | $39,999 | $13,756 |
| 2021 | 9 | 487 | 544 | $53,095 | $21,237 |
| 2020 | 8 | 382 | 421 | $38,753 | $17,950 |
Total Patients
1,547
Total Services
1,702
Medicare Billing
$67,666
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Facility | 2023 | 115 | 132 | $13,200 | $6,202 | 47.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 25 | 26 | $7,280 | $1,781 | 24.5% |
| 92004 | New patient complete exam of visual system | Facility | 2023 | 24 | 24 | $2,400 | $1,383 | 57.6% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2023 | 28 | 38 | $2,926 | $1,288 | 44.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 13 | 13 | $4,290 | $1,252 | 29.2% |
| 92083 | Exam of visual field with extended testing | Facility | 2023 | 40 | 48 | $4,656 | $837.41 | 18.0% |
| 92133 | Imaging of optic nerve | Facility | 2023 | 54 | 59 | $3,366 | $770.88 | 22.9% |
| 92134 | Imaging of retina | Facility | 2023 | 34 | 37 | $2,331 | $669.60 | 28.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 18 | 18 | $2,322 | $386.44 | 16.6% |
| 92020 | Exam of the internal drainage system of eye | Facility | 2023 | 11 | 12 | $396.00 | $152.70 | 38.6% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 76 | 86 | $8,780 | $4,218 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 49 | $6,842 | $3,061 | 44.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 30 | 30 | $8,400 | $2,136 | 25.4% |
| 92004 | New patient complete exam of visual system | Facility | 2022 | 21 | 21 | $2,100 | $1,009 | 48.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 16 | 16 | $5,150 | $950.32 | 18.5% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 26 | 27 | $2,079 | $807.69 | 38.8% |
| 92133 | Imaging of optic nerve | Facility | 2022 | 36 | 37 | $2,109 | $528.72 | 25.1% |
| 92083 | Exam of visual field with extended testing | Facility | 2022 | 26 | 26 | $2,522 | $450.72 | 17.9% |
| 92134 | Imaging of retina | Facility | 2022 | 24 | 25 | $1,575 | $439.42 | 27.9% |
| 92020 | Exam of the internal drainage system of eye | Facility | 2022 | 13 | 13 | $442.00 | $154.88 | 35.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2021 | 102 | 121 | $10,760 | $6,359 | 59.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2021 | 51 | 51 | $5,100 | $3,208 | 62.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 33 | 40 | $10,056 | $2,952 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 37 | $5,136 | $2,151 | 41.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2021 | 44 | 53 | $4,081 | $1,970 | 48.3% |
About Dr. Monique Root, O.D
Dr. Monique Root, O.D is a Optometrist healthcare provider based in W Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184623860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monique Root, O.D has received a total of $1,284 in payments from pharmaceutical and medical device companies, with $80.90 received in 2024. These payments were reported across 23 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,284).
As a Medicare-enrolled provider, Root has provided services to 1,547 Medicare beneficiaries, totaling 1,702 services with total Medicare billing of $67,666. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location W Des Moines, IA
- Active Since 07/15/2005
- Last Updated 04/26/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1184623860
Products in Payments
- TEPEZZA (Drug) $228.84
- Heru HMD (Device) $141.12
- VYZULTA (Drug) $138.73
- EYLEA (Biological) $119.16
- EYLEA AFLIBERCEPT INJECTION (Biological) $112.59
- LOTEMAX SM (Drug) $109.76
- PAXLOVID (Drug) $58.39
- ISTENT INJECT W (Device) $56.27
- AcrySof (Device) $35.48
- XIFAXAN (Drug) $30.46
- ISTENT (Device) $25.66
- JARDIANCE (Drug) $22.30
- TRINTELLIX (Drug) $19.86
- MIEBO (Drug) $19.82
- Aimovig (Biological) $17.58
- EUCRISA (Drug) $13.30
- Ozempic (Drug) $11.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.